Under BTBD9 deficiency, the activity of the D1R-mediated dopamine system may have reached its peak, which indicated a weakened D2R signaling but an increased D1R signaling in RLS syndrome (61), similar to augmentation states. The gene discussed is DRD1; the disease is Ulbright-Hodes syndrome.